摘要
原文 | 英語 |
---|---|
頁(從 - 到) | 6782-6793 |
頁數 | 12 |
期刊 | Journal of Virology |
卷 | 87 |
發行號 | 12 |
DOIs | |
出版狀態 | 已發佈 - 6月 2013 |
對外發佈 | 是 |
指紋
深入研究「Kaposi's sarcoma-Associated herpesvirus (KSHV) latency-Associated nuclear antigen regulates the KSHV epigenome by association with the histone demethylase KDM3A」主題。共同形成了獨特的指紋。引用此
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Kaposi's sarcoma-Associated herpesvirus (KSHV) latency-Associated nuclear antigen regulates the KSHV epigenome by association with the histone demethylase KDM3A. / Kim, K.Y.; Huerta, S.B.; Izumiya, C. 等.
於: Journal of Virology, 卷 87, 編號 12, 06.2013, p. 6782-6793.研究成果: 雜誌貢獻 › 文章 › 同行評審
}
TY - JOUR
T1 - Kaposi's sarcoma-Associated herpesvirus (KSHV) latency-Associated nuclear antigen regulates the KSHV epigenome by association with the histone demethylase KDM3A
AU - Kim, K.Y.
AU - Huerta, S.B.
AU - Izumiya, C.
AU - Wang, D.-H.
AU - Martinez, A.
AU - Shevchenko, B.
AU - Kung, H.-J.
AU - Campbell, M.
AU - Izumiya, Y.
N1 - 引用次數:30 Export Date: 5 March 2018 CODEN: JOVIA 通訊地址: Izumiya, Y.; Department of Dermatology, University of California, School of Medicine, Davis, United States; 電子郵件: yizumiya@ucdavis.edu 分析序列編號: GENBANK: NC_009333; 化學物質/CAS: Antigens, Viral; Histones; Jumonji Domain-Containing Histone Demethylases, 1.14.11.-; KDM3A protein, human, 1.14.11.-; Nuclear Proteins; latency-associated nuclear antigen 參考文獻: Cesarman, E., Chang, Y., Moore, P.S., Said, J.W., Knowles, D.M., Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas (1995) N. Engl. J. Med., 332, pp. 1186-1191; Dupin, N., Fisher, C., Kellam, P., Ariad, S., Tulliez, M., Franck, N., van Marck, E., Boshoff, C., Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma (1999) Proc. Natl. Acad. Sci. U.S.A., 96, pp. 4546-4551; Hu, J., Garber, A.C., Renne, R., The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells (2002) J. Virol., 76, pp. 11677-11687; Kelley-Clarke, B., De Leon-Vazquez, E., Slain, K., Barbera, A.J., Kaye, K.M., Role of Kaposi's sarcoma-associated herpesvirus C-terminal LANA chromosome binding in episome persistence (2009) J. Virol., 83, pp. 4326-4337; Kelley-Clarke, B., Ballestas, M.E., Komatsu, T., Kaye, K.M., Kaposi's sarcoma herpesvirus C-terminal LANA concentrates at pericentromeric and peri-telomeric regions of a subset of mitotic chromosomes (2007) Virology, 357, pp. 149-157; Komatsu, T., Ballestas, M.E., Barbera, A.J., Kelley-Clarke, B., Kaye, K.M., KSHV LANA1 binds DNA as an oligomer and residues N-terminal to the oligomerization domain are essential for DNA binding, replication, and episome persistence (2004) Virology, 319, pp. 225-236; Ye, F.C., Zhou, F.C., Yoo, S.M., Xie, J.P., Browning, P.J., Gao, S.J., Disruption of Kaposi's sarcoma-associated herpesvirus latent nuclear antigen leads to abortive episome persistence (2004) J. Virol., 78, pp. 11121-11129; Ganem, D., KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine (2010) J. Clin. Invest., 120, pp. 939-949; Mesri, E.A., Cesarman, E., Boshoff, C., Kaposi's sarcoma and its associated herpesvirus (2010) Nat. Rev. Cancer, 10, pp. 707-719; Verma, S.C., Lan, K., Robertson, E., Structure and function of latencyassociated nuclear antigen (2007) Curr. Top. Microbiol. Immunol., 312, pp. 101-136; Schulz, T.F., KSHV/HHV8-associated lymphoproliferations in the AIDS setting (2001) Eur. J. Cancer, 37, pp. 1217-1226; Kedes, D.H., Lagunoff, M., Renne, R., Ganem, D., Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus (1997) J. Clin. Invest., 100, pp. 2606-2610; Renne, R., Barry, C., Dittmer, D., Compitello, N., Brown, P.O., Ganem, D., Modulation of cellular and viral gene expression by the latencyassociated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (2001) J. Virol., 75, pp. 458-468; An, F.Q., Compitello, N., Horwitz, E., Sramkoski, M., Knudsen, E.S., Renne, R., The latency-associated nuclear antigen of Kaposi's sarcomaassociated herpesvirus modulates cellular gene expression and protects lymphoid cells from p16 INK4A-induced cell cycle arrest (2005) J. Biol. Chem., 280, pp. 3862-3874; Jeong, J.H., Orvis, J., Kim, J.W., McMurtrey, C.P., Renne, R., Dittmer, D.P., Regulation and autoregulation of the promoter for the latencyassociated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (2004) J. Biol. Chem., 279, pp. 16822-16831; Verma, S.C., Borah, S., Robertson, E.S., Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus up-regulates transcription of human telomerase reverse transcriptase promoter through interaction with transcription factor Sp1 (2004) J. Virol., 78, pp. 10348-10359; Friborg Jr., J., Kong, W., Hottiger, M.O., Nabel, G.J., p53 inhibition by the LANA protein of KSHV protects against cell death (1999) Nature, 402, pp. 889-894; Radkov, S.A., Kellam, P., Boshoff, C., The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells (2000) Nat. Med., 6, pp. 1121-1127; Murakami, Y., Yamagoe, S., Noguchi, K., Takebe, Y., Takahashi, N., Uehara, Y., Fukazawa, H., Ets-1-dependent expression of vascular endothelial growth factor receptors is activated by latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus through interaction with Daxx (2006) J. Biol. Chem., 281, pp. 28113-28121; Platt, G.M., Simpson, G.R., Mittnacht, S., Schulz, T.F., Latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts with RING3, a homolog of the Drosophila female sterile homeotic (fsh) gene (1999) J. Virol., 73, pp. 9789-9795; Lim, C., Gwack, Y., Hwang, S., Kim, S., Choe, J., The transcriptional activity of cAMP response element-binding protein-binding protein is modulated by the latency associated nuclear antigen of Kaposi's sarcomaassociated herpesvirus (2001) J. Biol. Chem., 276, pp. 31016-31022; Lan, K., Kuppers, D.A., Robertson, E.S., Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jkappa, the major downstream effector of the Notch signaling pathway (2005) J. Virol., 79, pp. 3468-3478; Lu, F., Day, L., Gao, S.J., Lieberman, P.M., Acetylation of the latencyassociated nuclear antigen regulates repression of Kaposi's sarcomaassociated herpesvirus lytic transcription (2006) J. Virol., 80, pp. 5273-5282; Lan, K., Kuppers, D.A., Verma, S.C., Robertson, E.S., Kaposi's sarcomaassociated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virusmediated control of latency (2004) J. Virol., 78, pp. 6585-6594; Krithivas, A., Fujimuro, M., Weidner, M., Young, D.B., Hayward, S.D., Protein interactions targeting the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus to cell chromosomes (2002) J. Virol., 76, pp. 11596-11604; Ottinger, M., Christalla, T., Nathan, K., Brinkmann, M.M., Viejo-Borbolla, A., Schulz, T.F., Kaposi's sarcoma-associated herpesvirus LANA-1 interacts with the short variant of BRD4 and releases cells from a BRD4-and BRD2/RING3-induced G1 cell cycle arrest (2006) J. Virol., 80, pp. 10772-10786; Sakakibara, S., Ueda, K., Nishimura, K., Do, E., Ohsaki, E., Okuno, T., Yamanishi, K., Accumulation of heterochromatin components on the terminal repeat sequence of Kaposi's sarcoma-associated herpesvirus mediated by the latency-associated nuclear antigen (2004) J. Virol., 78, pp. 7299-7310; Ellison, T.J., Izumiya, Y., Izumiya, C., Luciw, P.A., Kung, H.J., A comprehensive analysis of recruitment and transactivation potential of K-Rta and K-bZIP during reactivation of Kaposi's sarcoma-associated herpesvirus (2009) Virology, 387, pp. 76-88; Gunther, T., Grundhoff, A., The epigenetic landscape of latent Kaposi sarcoma-associated herpesvirus genomes (2010) PLoS Pathog, 6, pp. e1000935. , doi: 10.1371/journal.ppat.1000935; Toth, Z.., Maglinte, D.T., Lee, S.H., Lee, H.R., Wong, L.Y., Brulois, K.F., Lee, S., Jung, J.U., Epigenetic analysis of KSHV latent and lytic genomes (2010) PLoS Pathog, 6, pp. e1001013. , doi:10.1371/journal.ppat.1001013; Pedersen, M.T., Helin, K., Histone demethylases in development and disease (2010) Trends Cell Biol., 20, pp. 662-671; Yamane, K., Toumazou, C., Tsukada, Y., Erdjument-Bromage, H., Tempst, P., Wong, J., Zhang, Y., JHDM2A, a JmjC-containing H3K9 demethylase, facilitates transcription activation by androgen receptor (2006) Cell, 125, pp. 483-495; Shi, Y., Whetstine, J.R., Dynamic regulation of histone lysine methylation by demethylases (2007) Mol. Cell, 25, pp. 1-14; Krieg, A.J., Rankin, E.B., Chan, D., Razorenova, O., Fernandez, S., Giaccia, A.J., Regulation of the histone demethylase JMJD1A by hypoxiainducible factor 1 alpha enhances hypoxic gene expression and tumor growth (2010) Mol. Cell. Biol., 30, pp. 344-353; Shakya, A., Kang, J., Chumley, J., Williams, M.A., Tantin, D., Oct1 is a switchable, bipotential stabilizer of repressed and inducible transcriptional states (2011) J. Biol. Chem., 286, pp. 450-459; Liang, Y., Vogel, J.L., Narayanan, A., Peng, H., Kristie, T.M., Inhibition of the histone demethylase LSD1 blocks alpha-herpesvirus lytic replication and reactivation from latency (2009) Nat. Med., 15, pp. 1312-1317; Anderton, J.A., Bose, S., Vockerodt, M., Vrzalikova, K., Wei, W., Kuo, M., Helin, K., Woodman, C.B., The H3K27me3 demethylase, KDM6B, is induced by Epstein-Barr virus and over-expressed in Hodgkin's lymphoma (2011) Oncogene, 30, pp. 2037-2043; Chang, P.C., Fitzgerald, L.D., Hsia, D.A., Izumiya, Y., Wu, C.Y., Hsieh, W.P., Lin, S.F., Kung, H.J., Histone demethylase JMJD2A regulates Kaposi's sarcoma-associated herpesvirus replication and is targeted by a viral transcriptional factor (2011) J. Virol., 85, pp. 3283-3293; Nakamura, H., Lu, M., Gwack, Y., Souvlis, J., Zeichner, S.L., Jung, J.U., Global changes in Kaposi's sarcoma-associated virus gene expression patterns following expression of a tetracycline-inducible Rta transactivator (2003) J. Virol., 77, pp. 4205-4220; Vieira, J., O'Hearn, P.M., Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression (2004) Virology, 325, pp. 225-240; Izumiya, Y., Ellison, T.J., Yeh, E.T., Jung, J.U., Luciw, P.A., Kung, H.J., Kaposi's sarcoma-associated herpesvirus K-bZIP represses gene transcription via SUMO modification (2005) J. Virol., 79, pp. 9912-9925; Izumiya, Y., Izumiya, C., Hsia, D., Ellison, T.J., Luciw, P.A., Kung, H.J., NF-kappaB serves as a cellular sensor of Kaposi's sarcoma-associated herpesvirus latency and negatively regulates K-Rta by antagonizing the RBPJkappa coactivator (2009) J. Virol., 83, pp. 4435-4446; Campbell, M., Chang, P.C., Huerta, S., Izumiya, C., Davis, R., Tepper, C.G., Kim, K.Y., Izumiya, Y., Protein arginine methyltransferase 1-directed methylation of Kaposi sarcoma-associated herpesvirus latency-associated nuclear antigen (2012) J. Biol. Chem., 287, pp. 5806-5818; Izumiya, Y., Izumiya, C., Van Geelen, A., Wang, D.H., Lam, K.S., Luciw, P.A., Kung, H.J., Kaposi's sarcoma-associated herpesvirus-encoded protein kinase and its interaction with K-bZIP (2007) J. Virol., 81, pp. 1072-1082; Fakhari, F.D., Dittmer, D.P., Charting latency transcripts in Kaposi's sarcoma-associated herpesvirus by whole-genome real-time quantitative PCR (2002) J. Virol., 76, pp. 6213-6223; Xu, X., Hoang, S., Mayo, M.W., Bekiranov, S., Application of machine learning methods to histone methylation ChIP-Seq data reveals H4R3me2 globally represses gene expression (2010) BMC Bioinformatics, 11, p. 396. , doi:10.1186/1471-2105-11-396; Antonysamy, S., Bonday, Z., Campbell, R.M., Doyle, B., Druzina, Z., Gheyi, T., Han, B., Emtage, S., Crystal structure of the human PRMT5:MEP50 complex (2012) Proc. Natl. Acad. Sci. U.S.A., 109, pp. 17960-17965; Stewart, M.D., Li, J., Wong, J., Relationship between histone H3 lysine 9 methylation, transcription repression, and heterochromatin protein 1 recruitment (2005) Mol. Cell. Biol., 25, pp. 2525-2538; Collins, R.E., Northrop, J.P., Horton, J.R., Lee, D.Y., Zhang, X., Stallcup, M.R., Cheng, X., The ankyrin repeats of G9a and GLP histone methyltransferases are mono-and dimethyllysine binding modules (2008) Nat. Struct. Mol. Biol., 15, pp. 245-250; Stuber, G., Mattsson, K., Flaberg, E., Kati, E., Markasz, L., Sheldon, J.A., Klein, G., Szekely, L., HHV-8 encoded LANA-1 alters the higher organization of the cell nucleus (2007) Mol. Cancer, 6, p. 28. , doi:10.1186/1476-4598-6-28; Campbell, M., Izumiya, Y., Post-translational modifications of Kaposi's sarcoma-associated herpesvirus regulatory proteins-SUMO and KSHV (2012) Front. Microbiol, 3, p. 31. , doi:10.3389/fmicb.2012.00031; Lu, F., Tsai, K., Chen, H.S., Wikramasinghe, P., Davuluri, R.V., Showe, L., Domsic, J., Lieberman, P.M., Identification of hostchromosome binding sites and candidate gene targets for Kaposi's sarcoma-associated herpesvirus LANA (2012) J. Virol., 86, pp. 5752-5762; Wen, K.W., Dittmer, D.P., Damania, B., Disruption of LANA in rhesus rhadinovirus generates a highly lytic recombinant virus (2009) J. Virol., 83, pp. 9786-9802; Li, Q., Zhou, F., Ye, F., Gao, S.J., Genetic disruption of KSHV major latent nuclear antigen LANA enhances viral lytic transcriptional program (2008) Virology, 379, pp. 234-244; Chen, W., Dittmer, D.P., Ribosomal protein S6 interacts with the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (2011) J. Virol., 85, pp. 9495-9505; Barbera, A.J., Chodaparambil, J.V., Kelley-Clarke, B., Joukov, V., Walter, J.C., Luger, K., Kaye, K.M., The nucleosomal surface as a docking station for Kaposi's sarcoma herpesvirus LANA (2006) Science, 311, pp. 856-861; Wissmann, M., Yin, N., Muller, J.M., Greschik, H., Fodor, B.D., Jenuwein, T., Vogler, C., Schule, R., Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression (2007) Nat. Cell Biol., 9, pp. 347-353; Davis, D.A., Rinderknecht, A.S., Zoeteweij, J.P., Aoki, Y., Read-Connole, E.L., Tosato, G., Blauvelt, A., Yarchoan, R., Hypoxia induces lytic replication of Kaposi sarcoma-associated herpesvirus (2001) Blood, 97, pp. 3244-3250; Shin, Y.C., Joo, C.H., Gack, M.U., Lee, H.R., Jung, J.U., Kaposi's sarcomaassociated herpesvirus viral IFN regulatory factor 3 stabilizes hypoxiainducible factor-1 alpha to induce vascular endothelial growth factor expression (2008) Cancer Res., 68, pp. 1751-1759; Carroll, P.A., Kenerson, H.L., Yeung, R.S., Lagunoff, M., Latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells activates hypoxia-induced factors (2006) J. Virol., 80, pp. 10802-10812; Cai, Q., Murakami, M., Si, H., Robertson, E.S., A potential alpha-helix motif in the amino terminus of LANA encoded by Kaposi's sarcomaassociated herpesvirus is critical for nuclear accumulation of HIF-1alpha in normoxia (2007) J. Virol., 81, pp. 10413-10423; Mimura, I., Nangaku, M., Kanki, Y., Tsutsumi, S., Inoue, T., Kohro, T., Yamamoto, S., Wada, Y., Dynamic change of chromatin conformation in response to hypoxia enhances the expression of GLUT3 (SLC2A3) by cooperative interaction of hypoxia-inducible factor 1 and KDM3A (2012) Mol. Cell. Biol., 32, pp. 3018-3032; Veeranna, R.P., Haque, M., Davis, D.A., Yang, M., Yarchoan, R., Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen induction by hypoxia and hypoxia-inducible factors (2012) J. Virol., 86, pp. 1097-1108; Cho, H.S., Toyokawa, G., Daigo, Y., Hayami, S., Masuda, K., Ikawa, N., Yamane, Y., Hamamoto, R., The JmjC domaincontaining histone demethylase KDM3A is a positive regulator of the G(1)/S transition in cancer cells via transcriptional regulation of the HOXA1 gene (2012) Int. J. Cancer, 131, pp. E179-E189. , doi:10.1002/ijc.26501; Guo, X., Shi, M., Sun, L., Wang, Y., Gui, Y., Cai, Z., Duan, X., The expression of histone demethylase JMJD1A in renal cell carcinoma (2011) Neoplasma, 58, pp. 153-157; Bjorkman, M., Ostling, P., Harma, V., Virtanen, J., Mpindi, J.P., Rantala, J., Mirtti, T., Nees, M., Systematic knockdown of epigenetic enzymes identifies a novel histone demethylase PHF8 overexpressed in prostate cancer with an impact on cell proliferation, migration and invasion (2012) Oncogene, 31, pp. 3444-3456
PY - 2013/6
Y1 - 2013/6
N2 - Kaposi's sarcoma-associated herpesvirus (KSHV) latent genomes are tethered to host histones to form a minichromosome also known as an "episome." Histones, which are core components of chromatin, are heavily modified by various histone-targetingenzymes. Posttranslational modifications of histones significantly influence accessibility of transcriptional factors and thus have profound effects on gene expression. Recent studies showed that epigenetic marks on the KSHV episome are well organized, exemplified by the absence of histone H3 lysine 9 (H3K9) methylation, a heterochromatic histone mark, from immediate early andlatent gene promoters in naturally infected cells. The present study revealed a mechanistic insight into KSHV epigenome regulationvia a complex consisting of LANA and the H3K9me1/2 histone demethylase JMJD1A/KDM3A. This complex was isolatedfrom HeLa cell nuclear extracts stably expressing LANA and was verified by coimmunoprecipitation analyses and with purifiedproteins. LANA recruitment sites on the KSHV genome inversely correlated with H3K9me2 histone marks in naturally infectedcells, and methylation of H3K9 significantly inhibited LANA binding to the histone H3 tail. Chromatin immunoprecipitationcoupled with KSHV tiling arrays identified the recruitment sites of the complex, while depletion of LANA expression or overexpressionof a KDM3A binding-deficient mutant decreased KDM3A recruitment to the KSHV genome. Finally, ablation ofKDM3A expression from latently KSHV-infected cells significantly inhibited KSHV gene expression, leading to decreased KSHVreplication during reactivation. Taken together, our results suggest that LANA may play a role in regulation of epigenetic markson the KSHV genome, which is in part through association with the histone demethylase KDM3A. © 2013, American Society for Microbiology.
AB - Kaposi's sarcoma-associated herpesvirus (KSHV) latent genomes are tethered to host histones to form a minichromosome also known as an "episome." Histones, which are core components of chromatin, are heavily modified by various histone-targetingenzymes. Posttranslational modifications of histones significantly influence accessibility of transcriptional factors and thus have profound effects on gene expression. Recent studies showed that epigenetic marks on the KSHV episome are well organized, exemplified by the absence of histone H3 lysine 9 (H3K9) methylation, a heterochromatic histone mark, from immediate early andlatent gene promoters in naturally infected cells. The present study revealed a mechanistic insight into KSHV epigenome regulationvia a complex consisting of LANA and the H3K9me1/2 histone demethylase JMJD1A/KDM3A. This complex was isolatedfrom HeLa cell nuclear extracts stably expressing LANA and was verified by coimmunoprecipitation analyses and with purifiedproteins. LANA recruitment sites on the KSHV genome inversely correlated with H3K9me2 histone marks in naturally infectedcells, and methylation of H3K9 significantly inhibited LANA binding to the histone H3 tail. Chromatin immunoprecipitationcoupled with KSHV tiling arrays identified the recruitment sites of the complex, while depletion of LANA expression or overexpressionof a KDM3A binding-deficient mutant decreased KDM3A recruitment to the KSHV genome. Finally, ablation ofKDM3A expression from latently KSHV-infected cells significantly inhibited KSHV gene expression, leading to decreased KSHVreplication during reactivation. Taken together, our results suggest that LANA may play a role in regulation of epigenetic markson the KSHV genome, which is in part through association with the histone demethylase KDM3A. © 2013, American Society for Microbiology.
KW - histone demethylase
KW - histone H3
KW - latency associated nuclear antigen
KW - protein KDM3A
KW - unclassified drug
KW - amino terminal sequence
KW - article
KW - binding site
KW - chromatin immunoprecipitation
KW - complex formation
KW - controlled study
KW - embryo
KW - epigenetics
KW - gene control
KW - gene expression regulation
KW - genetic association
KW - histone methylation
KW - human
KW - human cell
KW - Human herpesvirus 8
KW - nonhuman
KW - nucleotide sequence
KW - priority journal
KW - protein binding
KW - protein expression
KW - protein protein interaction
KW - protein purification
KW - virus gene
KW - virus genome
KW - virus latency
KW - virus reactivation
KW - virus replication
KW - Antigens, Viral
KW - Chromatin Immunoprecipitation
KW - DNA Replication
KW - Epigenesis, Genetic
KW - Gene Expression Regulation, Viral
KW - Genome, Viral
KW - HEK293 Cells
KW - HeLa Cells
KW - Herpesvirus 8, Human
KW - Histones
KW - Host-Pathogen Interactions
KW - Humans
KW - Jumonji Domain-Containing Histone Demethylases
KW - Nuclear Proteins
KW - Oligonucleotide Array Sequence Analysis
KW - Virus Latency
U2 - 10.1128/JVI.00011-13
DO - 10.1128/JVI.00011-13
M3 - Article
VL - 87
SP - 6782
EP - 6793
JO - Journal of Virology
JF - Journal of Virology
SN - 0022-538X
IS - 12
ER -